Document is current
Any future updates will be listed below
-
Authors
Cárdenas, Santiago D.
Reznik, Constance J.
Ranaweera, Ruchira
Song, Feifei
Chung, Christine H. https://orcid.org/0000-0001-5199-4306
Fertig, Elana J. https://orcid.org/0000-0003-3204-342X
Gevertz, Jana L.
- License Information
-
More Information
Article History
Received: 18 February 2022
Accepted: 5 August 2022
First Online: 8 September 2022
Competing interests
: The authors declare the following financial competing interests: E.J.F. is on the Scientific Advisory Board of ResistanceBio/Viosera Therapeutics and is a paid consultant to Merck and Mestag Therapeutics. C.H.C. has honoraria from Bristol-Myers Squibb, CUE, Sanofi, Mirati, Merck, Brooklyn ImmunoTherapuetics, and Exelixis for ad hoc Scientific Advisory Board participation. R.R. was affiliated with Moffitt at the time of data generation, but employed by BMS at time of submission. All authors declare no non-financial competing interests.
